Detalhe da pesquisa
1.
Impact of the lactate dehydrogenase in association with the International Staging System prognostic score in multiple myeloma patients treated in real life.
Hematol Transfus Cell Ther
; 45(2): 259-265, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114115
2.
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients.
Hematol Transfus Cell Ther
; 43 Suppl 2: S30-S34, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794794
3.
Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients.
Hematol Transfus Cell Ther
; 42(2): 159-163, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31519532
4.
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation.
Hematol Transfus Cell Ther
; 42(2): 118-124, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537476
5.
New proteasome inhibitors in the treatment of multiple myeloma.
Hematol Transfus Cell Ther
; 41(1): 76-83, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30793108
6.
Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries.
Clin Lymphoma Myeloma Leuk
; 19(1): e43-e50, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297171
7.
Multiple myeloma and central nervous system involvement: experience of a Brazilian center.
Rev Bras Hematol Hemoter
; 40(1): 30-36, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29519370
8.
Impact of the lactate dehydrogenase in association with the International Staging System prognostic score in multiple myeloma patients treated in real life
Hematol., Transfus. Cell Ther. (Impr.)
; 45(2): 259-265, Apr.-June 2023. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-1448341
9.
For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission.
Rev Bras Hematol Hemoter
; 39(4): 331-336, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29150105
10.
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.
Hematol Transfus Cell Ther
; 44(3): 410-418, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970751
11.
Liposomal daunorubicin and dexamethasone as a treatment for multiple myeloma--the DD Protocol.
Sao Paulo Med J
; 123(6): 266-70, 2005 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-16444385
12.
Up-front autologous hematopoietic stem cell transplantation (AHSCT) from a single Brazilian center.
Bone Marrow Transplant
; 55(6): 1181-1183, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471574
13.
Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
Hematol., Transfus. Cell Ther. (Impr.)
; 42(2): 118-124, Apr.-June 2020. tab, ilus
Artigo
em Inglês
| LILACS | ID: biblio-1134012
14.
Outcomes of autologous transplantation for multiple myeloma according to different induction regimens.
Rev Bras Hematol Hemoter
; 36(1): 19-24, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24624031
15.
New proteasome inhibitors in the treatment of multiple myeloma
Hematol., Transfus. Cell Ther. (Impr.)
; 41(1): 76-83, Jan.-Mar. 2019. tab, ilus
Artigo
em Inglês
| LILACS | ID: biblio-1002040
16.
Multiple myeloma and central nervous system involvement: experience of a Brazilian center
Hematol., Transfus. Cell Ther. (Impr.)
; 40(1): 30-36, Jan.-Mar. 2018. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-953805
17.
For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission
Rev. bras. hematol. hemoter
; 39(4): 331-336, Oct.-Dec. 2017. tab, graf
Artigo
em Inglês
| LILACS | ID: biblio-898942
18.
Guidelines on the diagnosis and management of multiple myeloma treatment: Associac ao Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I
Hematol., Transfus. Cell Ther. (Impr.)
; 44(3): 410-418, July-Sept. 2022.
Artigo
em Inglês
| LILACS | ID: biblio-1405010
19.
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
Rev. bras. hematol. hemoter
; 38(1): 37-43, Jan.-Feb. 2016. tab, graf
Artigo
em Inglês
| LILACS | ID: lil-777421
20.
Bilateral breast plasmacytoma: a clinical case report.
Rev Bras Hematol Hemoter
; 38(2): 166-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27208578